DURHAM, N.C., Sept. 3, 2010 GLOBE NEWSWIRE — Oxygen Biotherapeutics, Inc. Nasdaq:OXBT SIX Swiss Exchange:OXBT, a development stage biomedical company focused on developing oxygen-rich intravenous and topical products, today announced that the company will report first quarter fiscal year 2011 financial results following the close of the U.S. financial markets on Thursday, September 9, 2010.
The [...] http://bit.ly/9lypkY
No comments:
Post a Comment